Finance

Lists
RHY:ASX
Rhythm Biosciences Ltd
A$0,080
-1,23%
(-0,0010) 1D
2 Okt., 17:10:22 GMT+11  ·   AUD
All symbols
SymbolPriceChange% Change
Generating top insights for RHY...
Open
A$0,08
High
A$0,08
Low
A$0,08
Mkt. cap
28,66 m
Avg. vol.
259,21 k
Volume
15,56 k
52-wk high
A$0,28
52-wk low
A$0,08
EPS
-A$0,02
Shares outstanding
364,06 m
Open
A$0,08
High
A$0,08
Low
A$0,08
Mkt. cap
28,66 m
Avg. vol.
259,21 k
Volume
15,56 k
52-wk high
A$0,28
52-wk low
A$0,08
EPS
-A$0,02
Shares outstanding
364,06 m
News stories
From web sources and news partners
About Rhythm Biosciences Ltd
CEOTrevor Lockett
Employees-
Founded2017
Headquarters-
SectorHealth care provider
Previous reportsAll values in AUD
Loading Previous Earnings...
Revenue
Net income
All values in AUD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
811,07 k
811,07 k
59,29 k
59,29 k
Cost of goods sold
385,44 k
385,44 k
-179,08 k
-179,08 k
Cost of revenue
385,44 k
385,44 k
-179,08 k
-179,08 k
Research and development expenses
-
-
519,97 k
519,97 k
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1,49 m
1,49 m
1,49 m
1,49 m
Operating expense
1,53 m
1,53 m
2,06 m
2,06 m
Total operating expenses
1,92 m
1,92 m
1,88 m
1,88 m
Operating income
-1,11 m
-1,11 m
-1,82 m
-1,82 m
Other non operating income
-
-
-
-
EBT including unusual items
-1,13 m
-1,13 m
-1,84 m
-1,84 m
EBT excluding unusual items
-1,13 m
-1,13 m
-1,84 m
-1,84 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1,13 m
-1,13 m
-1,84 m
-1,84 m
Net profit margin
-139,15%
-139,15%
-3 097,39%
-3 097,39%
Earnings per share
-
-
-
-
Interest and investment income
15,09 k
15,09 k
-
-
Interest expense
-34,76 k
-34,76 k
-17,73 k
-17,73 k
Net interest expenses
-19,67 k
-19,67 k
-17,73 k
-17,73 k
Depreciation and amortization charges
40,42 k
40,42 k
45,23 k
45,23 k
EBITDA
-1,06 m
-1,06 m
-1,77 m
-1,77 m
Gain or loss from assets sale
-
-
-1,52 k
-1,52 k
AI content may include mistakes. Learn more
Google-programme